194 related articles for article (PubMed ID: 34228536)
1. Exebacase Is Active
Swift SM; Sauve K; Cassino C; Schuch R
Antimicrob Agents Chemother; 2021 Aug; 65(9):e0272320. PubMed ID: 34228536
[TBL] [Abstract][Full Text] [Related]
2. Effect of the Lysin Exebacase on Cardiac Vegetation Progression in a Rabbit Model of Methicillin-Resistant Staphylococcus aureus Endocarditis as Determined by Echocardiography.
Shah SU; Xiong YQ; Abdelhady W; Iwaz J; Pak Y; Schuch R; Cassino C; Lehoux D; Bayer AS
Antimicrob Agents Chemother; 2020 Jun; 64(7):. PubMed ID: 32340988
[TBL] [Abstract][Full Text] [Related]
3. Synergistic Activity of Exebacase (CF-301) in Addition to Daptomycin against Staphylococcus aureus in a Neutropenic Murine Thigh Infection Model.
Asempa TE; Abdelraouf K; Carabeo T; Schuch R; Nicolau DP
Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31818816
[TBL] [Abstract][Full Text] [Related]
4. Exebacase in Addition to Daptomycin against MRSA.
Kebriaei R; Stamper KC; Lev KL; Morrisette T; Abdul-Mutakabbir JC; Schuch R; Lehoux D; Rybak MJ
Antimicrob Agents Chemother; 2021 Oct; 65(11):e0012821. PubMed ID: 34398668
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of Exebacase (CF-301) against clinical Staphylococcus aureus surveillance isolates from the United States, Europe, and Latin America, 2015-2017.
Traczewski M; Oh J; Cassino C; Schuch R
Diagn Microbiol Infect Dis; 2019 Dec; 95(4):114879. PubMed ID: 31466875
[TBL] [Abstract][Full Text] [Related]
6. Exebacase in Addition to Standard-of-Care Antibiotics for Staphylococcus aureus Bloodstream Infections and Right-Sided Infective Endocarditis: A Phase 3, Superiority-Design, Placebo-Controlled, Randomized Clinical Trial (DISRUPT).
Fowler VG; Das AF; Lipka-Diamond J; Ambler JE; Schuch R; Pomerantz R; Cassino C; Jáuregui-Peredo L; Moran GJ; Rupp ME; Lachiewicz AM; Kuti JL; Wise RA; Kaye KS; Zervos MJ; Nichols WG
Clin Infect Dis; 2024 Jun; 78(6):1473-1481. PubMed ID: 38297916
[TBL] [Abstract][Full Text] [Related]
7. The Lysin Exebacase Has a Low Propensity for Resistance Development in Staphylococcus aureus and Suppresses the Emergence of Resistance to Antistaphylococcal Antibiotics.
Oh J; Warner M; Ambler JE; Schuch R
Microbiol Spectr; 2023 Mar; 11(2):e0526122. PubMed ID: 36862002
[TBL] [Abstract][Full Text] [Related]
8. Exebacase Demonstrates
Watson A; Sauve K; Cassino C; Schuch R
Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31712212
[No Abstract] [Full Text] [Related]
9. Exebacase in Addition to Daptomycin Is More Active than Daptomycin or Exebacase Alone in Methicillin-Resistant Staphylococcus aureus Osteomyelitis in Rats.
Karau MJ; Schmidt-Malan SM; Yan Q; Greenwood-Quaintance KE; Mandrekar J; Lehoux D; Schuch R; Cassino C; Patel R
Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31358593
[TBL] [Abstract][Full Text] [Related]
10. Efficacy assessment of lysin CF-296 in addition to daptomycin or vancomycin against Staphylococcus aureus in the murine thigh infection model.
Asempa TE; DeRosa NA; Cassino C; Lehoux D; Schuch R; Nicolau DP
J Antimicrob Chemother; 2021 Sep; 76(10):2622-2628. PubMed ID: 34223628
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of exebacase against methicillin-resistant Staphylococcus aureus biofilms on orthopedic Kirschner wires.
Karau MJ; Mandrekar J; Lehoux D; Schuch R; Cassino C; Patel R
BMC Res Notes; 2023 Sep; 16(1):209. PubMed ID: 37697424
[TBL] [Abstract][Full Text] [Related]
12. Activity of Exebacase (CF-301) against Biofilms Formed by Staphylococcus epidermidis Strains Isolated from Prosthetic Joint Infections.
Souche A; Kolenda C; Teoli J; Schuch R; Ferry T; Laurent F; Josse J
Antimicrob Agents Chemother; 2022 Aug; 66(8):e0058822. PubMed ID: 35861539
[TBL] [Abstract][Full Text] [Related]
13. Exebacase for patients with Staphylococcus aureus bloodstream infection and endocarditis.
Fowler VG; Das AF; Lipka-Diamond J; Schuch R; Pomerantz R; Jáuregui-Peredo L; Bressler A; Evans D; Moran GJ; Rupp ME; Wise R; Corey GR; Zervos M; Douglas PS; Cassino C
J Clin Invest; 2020 Jul; 130(7):3750-3760. PubMed ID: 32271718
[TBL] [Abstract][Full Text] [Related]
14. Safety and Pharmacokinetics of Exebacase in an Infant With Disseminated Staphylococcus aureus Infection.
Moorthy GS; Greenberg RG; Hornik CD; Cassino C; Ghahramani P; Kumar KR; Fowler VG; Cohen-Wolkowiez M
Clin Infect Dis; 2022 Aug; 75(2):338-341. PubMed ID: 34894129
[TBL] [Abstract][Full Text] [Related]
15. The Antistaphylococcal Lysin, CF-301, Activates Key Host Factors in Human Blood To Potentiate Methicillin-Resistant
Indiani C; Sauve K; Raz A; Abdelhady W; Xiong YQ; Cassino C; Bayer AS; Schuch R
Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30670427
[TBL] [Abstract][Full Text] [Related]
16. Locally delivered antistaphylococcal lysin exebacase or CF-296 is active in methicillin-resistant
Karau M; Schmidt-Malan S; Mandrekar J; Lehoux D; Schuch R; Cassino C; Patel R
J Bone Jt Infect; 2022; 7(4):169-175. PubMed ID: 36032801
[No Abstract] [Full Text] [Related]
17. Determination of MIC Quality Control Parameters for Exebacase, a Novel Lysin with Antistaphylococcal Activity.
Traczewski MM; Ambler JE; Schuch R
J Clin Microbiol; 2021 Jun; 59(7):e0311720. PubMed ID: 33910968
[TBL] [Abstract][Full Text] [Related]
18. Postantibiotic and Sub-MIC Effects of Exebacase (Lysin CF-301) Enhance Antimicrobial Activity against Staphylococcus aureus.
Oh JT; Cassino C; Schuch R
Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30936103
[TBL] [Abstract][Full Text] [Related]
19. In vivo efficacy of daptomycin against methicillin-resistant Staphylococcus aureus in a mouse model of hematogenous pulmonary infection.
Harada Y; Yanagihara K; Yamada K; Migiyama Y; Nagaoka K; Morinaga Y; Nakamura S; Imamura Y; Hasegawa H; Miyazaki T; Izumikawa K; Kakeya H; Kohno S
Antimicrob Agents Chemother; 2013 Jun; 57(6):2841-4. PubMed ID: 23507279
[TBL] [Abstract][Full Text] [Related]
20. Combination therapy with lysin CF-301 and antibiotic is superior to antibiotic alone for treating methicillin-resistant Staphylococcus aureus-induced murine bacteremia.
Schuch R; Lee HM; Schneider BC; Sauve KL; Law C; Khan BK; Rotolo JA; Horiuchi Y; Couto DE; Raz A; Fischetti VA; Huang DB; Nowinski RC; Wittekind M
J Infect Dis; 2014 May; 209(9):1469-78. PubMed ID: 24286983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
